Mercuric chloride, but not methylmercury, inhibits glutamine synthetase activity in primary cultures of cortical astrocytes

Jeffrey W. Allen, Lysette A. Mutkus, Michael Aschner

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Methylmercury (MeHg) is highly neurotoxic with an apparent dose-related latency period between time of exposure and the appearance of symptoms. Astrocytes are known targets for MeHg toxicity and a site of mercury localization within the central nervous system (CNS). Glutamine synthetase (GS) is an enzyme localized predominately within astrocytes. GS converts two potentially toxic molecules, glutamate and ammonia, to the relatively non-toxic amino acid, glutamine. During prolonged exposure to MeHg, inorganic mercury (I-Hg) accumulates within the brain, suggesting in situ demethylation of MeHg to I-Hg. To determine if speciation of mercurials would differentially alter GS activity and expression, neonatal rat primary astrocyte cultures were exposed to MeHg or mercuric chloride (HgCl2) for 1 or 6 h. MeHg produced no changes in GS activity, protein, or mRNA at any time or dose tested. In contrast, HgCl2 produced a dose dependent decrease in astrocytic GS activity at both 1 and 6 h. There were no changes in GS protein or mRNA levels following HgCl2 exposure. Additional studies were carried out to determine GS activity in cell lysates incubated with HgCl2 or MeHg. In cell lysates, HgCl2 was three-times more potent than MeHg in inhibiting GS activity. The inhibition of GS activity in cell lysates by HgCl2 was reversed by the addition of dithiothreitol (DTT), while DTT did not restore GS activity following MeHg. These data suggest that astrocytic GS activity is not inhibited by physiologically relevant concentrations of MeHg, but is inhibited by I-Hg, which is present in CNS following chronic MeHg exposure.

Original languageEnglish (US)
Pages (from-to)148-157
Number of pages10
JournalBrain Research
Volume891
Issue number1-2
DOIs
StatePublished - Feb 9 2001
Externally publishedYes

Fingerprint

Mercuric Chloride
Glutamate-Ammonia Ligase
Astrocytes
Dithiothreitol
Mercury
Central Nervous System
Messenger RNA
Poisons
Glutamine
Ammonia
Glutamic Acid
Proteins

Keywords

  • Astrocytes
  • Glutamine synthetase
  • Mercury
  • Methylmercury

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Mercuric chloride, but not methylmercury, inhibits glutamine synthetase activity in primary cultures of cortical astrocytes. / Allen, Jeffrey W.; Mutkus, Lysette A.; Aschner, Michael.

In: Brain Research, Vol. 891, No. 1-2, 09.02.2001, p. 148-157.

Research output: Contribution to journalArticle

@article{a8d16d532f9241eb9586cea23b165198,
title = "Mercuric chloride, but not methylmercury, inhibits glutamine synthetase activity in primary cultures of cortical astrocytes",
abstract = "Methylmercury (MeHg) is highly neurotoxic with an apparent dose-related latency period between time of exposure and the appearance of symptoms. Astrocytes are known targets for MeHg toxicity and a site of mercury localization within the central nervous system (CNS). Glutamine synthetase (GS) is an enzyme localized predominately within astrocytes. GS converts two potentially toxic molecules, glutamate and ammonia, to the relatively non-toxic amino acid, glutamine. During prolonged exposure to MeHg, inorganic mercury (I-Hg) accumulates within the brain, suggesting in situ demethylation of MeHg to I-Hg. To determine if speciation of mercurials would differentially alter GS activity and expression, neonatal rat primary astrocyte cultures were exposed to MeHg or mercuric chloride (HgCl2) for 1 or 6 h. MeHg produced no changes in GS activity, protein, or mRNA at any time or dose tested. In contrast, HgCl2 produced a dose dependent decrease in astrocytic GS activity at both 1 and 6 h. There were no changes in GS protein or mRNA levels following HgCl2 exposure. Additional studies were carried out to determine GS activity in cell lysates incubated with HgCl2 or MeHg. In cell lysates, HgCl2 was three-times more potent than MeHg in inhibiting GS activity. The inhibition of GS activity in cell lysates by HgCl2 was reversed by the addition of dithiothreitol (DTT), while DTT did not restore GS activity following MeHg. These data suggest that astrocytic GS activity is not inhibited by physiologically relevant concentrations of MeHg, but is inhibited by I-Hg, which is present in CNS following chronic MeHg exposure.",
keywords = "Astrocytes, Glutamine synthetase, Mercury, Methylmercury",
author = "Allen, {Jeffrey W.} and Mutkus, {Lysette A.} and Michael Aschner",
year = "2001",
month = "2",
day = "9",
doi = "10.1016/S0006-8993(00)03185-1",
language = "English (US)",
volume = "891",
pages = "148--157",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Mercuric chloride, but not methylmercury, inhibits glutamine synthetase activity in primary cultures of cortical astrocytes

AU - Allen, Jeffrey W.

AU - Mutkus, Lysette A.

AU - Aschner, Michael

PY - 2001/2/9

Y1 - 2001/2/9

N2 - Methylmercury (MeHg) is highly neurotoxic with an apparent dose-related latency period between time of exposure and the appearance of symptoms. Astrocytes are known targets for MeHg toxicity and a site of mercury localization within the central nervous system (CNS). Glutamine synthetase (GS) is an enzyme localized predominately within astrocytes. GS converts two potentially toxic molecules, glutamate and ammonia, to the relatively non-toxic amino acid, glutamine. During prolonged exposure to MeHg, inorganic mercury (I-Hg) accumulates within the brain, suggesting in situ demethylation of MeHg to I-Hg. To determine if speciation of mercurials would differentially alter GS activity and expression, neonatal rat primary astrocyte cultures were exposed to MeHg or mercuric chloride (HgCl2) for 1 or 6 h. MeHg produced no changes in GS activity, protein, or mRNA at any time or dose tested. In contrast, HgCl2 produced a dose dependent decrease in astrocytic GS activity at both 1 and 6 h. There were no changes in GS protein or mRNA levels following HgCl2 exposure. Additional studies were carried out to determine GS activity in cell lysates incubated with HgCl2 or MeHg. In cell lysates, HgCl2 was three-times more potent than MeHg in inhibiting GS activity. The inhibition of GS activity in cell lysates by HgCl2 was reversed by the addition of dithiothreitol (DTT), while DTT did not restore GS activity following MeHg. These data suggest that astrocytic GS activity is not inhibited by physiologically relevant concentrations of MeHg, but is inhibited by I-Hg, which is present in CNS following chronic MeHg exposure.

AB - Methylmercury (MeHg) is highly neurotoxic with an apparent dose-related latency period between time of exposure and the appearance of symptoms. Astrocytes are known targets for MeHg toxicity and a site of mercury localization within the central nervous system (CNS). Glutamine synthetase (GS) is an enzyme localized predominately within astrocytes. GS converts two potentially toxic molecules, glutamate and ammonia, to the relatively non-toxic amino acid, glutamine. During prolonged exposure to MeHg, inorganic mercury (I-Hg) accumulates within the brain, suggesting in situ demethylation of MeHg to I-Hg. To determine if speciation of mercurials would differentially alter GS activity and expression, neonatal rat primary astrocyte cultures were exposed to MeHg or mercuric chloride (HgCl2) for 1 or 6 h. MeHg produced no changes in GS activity, protein, or mRNA at any time or dose tested. In contrast, HgCl2 produced a dose dependent decrease in astrocytic GS activity at both 1 and 6 h. There were no changes in GS protein or mRNA levels following HgCl2 exposure. Additional studies were carried out to determine GS activity in cell lysates incubated with HgCl2 or MeHg. In cell lysates, HgCl2 was three-times more potent than MeHg in inhibiting GS activity. The inhibition of GS activity in cell lysates by HgCl2 was reversed by the addition of dithiothreitol (DTT), while DTT did not restore GS activity following MeHg. These data suggest that astrocytic GS activity is not inhibited by physiologically relevant concentrations of MeHg, but is inhibited by I-Hg, which is present in CNS following chronic MeHg exposure.

KW - Astrocytes

KW - Glutamine synthetase

KW - Mercury

KW - Methylmercury

UR - http://www.scopus.com/inward/record.url?scp=0035830692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035830692&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(00)03185-1

DO - 10.1016/S0006-8993(00)03185-1

M3 - Article

C2 - 11164818

AN - SCOPUS:0035830692

VL - 891

SP - 148

EP - 157

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -